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Abstract
Background The technologies currently available to detect the
presence of foetal genetic abnormalities are complex, and undergo-
ing prenatal diagnostic testing can have wide-ranging repercus-
sions. Before individuals can decide with certainty whether or not
to take these tests, they ﬁrst need to grasp the many psychosocial
and clinical dimensions of prenatal genetic testing.
Objective To test a model integrating key psychosocial and clinical
factors as predictors of decisional conﬂict in decisions about
whether or not to undergo prenatal genetic testing.
Method Adults (n = 457) read one of four hypothetical scenarios
asking them to imagine expecting a child and considering the
option of a prenatal test able to detect a genetic condition; age
of condition onset (birth vs. adulthood) and its curability (no
cure vs. curable) were manipulated. Participants completed mea-
sures of decisional conﬂict, perceived beneﬁts from normal
results, test response eﬃcacy, condition coherence, child-related
worry, perceived disagreement with the other parent’s preference,
motivation to comply with doctors’ perceived preferences, and
parity.
Results Prenatal testing decisional conﬂict was positively predicted
by perceiving normal results as beneﬁcial, doubting the test’s reli-
ability, lacking understanding of the genetic condition, worrying
about the health of the foetus, perceiving diﬀerences of opinion
from partner/spouse, wanting to follow doctors’ preferences, and
being childless.
Discussion These results, of growing relevance given the increas-
ing availability of new technologies in pregnancy care, can
inform communication strategies that facilitate couples’ decision
making.
Conclusion This study provides insights into factors that might
complicate prenatal testing decision making.
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Introduction
With the rapid development of prenatal tests
for genetic conditions,1,2 expectant parents are
increasingly facing decisions as to whether or not
to undergo testing to determine whether their
unborn children have anomalies linked with spe-
ciﬁc health conditions. And as the numbers of
Western women becoming pregnant later in life
increase,3,4 so do their risks of carrying a foetus
with Down syndrome5 and other chromosomal
abnormalities.6 Diagnostic tests (e.g., amniocen-
tesis) can detect foetal chromosomal anomalies
but are associated with risk miscarriage risks
(e.g., approximately 1 in 300 to 500 for amnio-
centesis).7 Given these risks, individuals deciding
whether to undergo prenatal diagnostic testing
are likely to experience decisional conﬂict.8 This
state of psychological distress is central to the
decision-making theory,9 which posits that deci-
sions are diﬃcult to make if they are time con-
strained and involve options that are risky,
irreversible, and emotionally laden. Uncertainty
and subsequent distress-associated prenatal diag-
nostic testing could be minimized by health pro-
fessionals if concerns are identiﬁed and addressed
through patient education and counselling. Yet,
to date, theory and research on predictors of deci-
sional conﬂict over prenatal diagnostic testing are
lacking. Previous studies on decisional conﬂict in
the context of prenatal testing have shown that
informed decision making is associated with
lower decisional conﬂict,10,11 and that decision
aids (i.e., educational materials) and genetic
counselling can reduce feelings of conﬂict related
to making these choices.12,13 Yet to our knowl-
edge, no studies have examined which values,
beliefs, social inﬂuences, personal experiences, or
condition characteristics predict decisional con-
ﬂict over prenatal diagnostic testing. This study
was conducted to address this research gap.
Psychosocial and clinical predictors of
decisional conflict with prenatal diagnostic
testing
Drawing on theories of health decision making
and behaviour and guided by a review of empiri-
cal evidence, we developed a model integrating
psychosocial and clinical factors likely to inﬂu-
ence decisional conﬂict with prenatal diagnostic
testing experienced by would-be parents, irre-
spective of their age. This proposed model
(Fig. 1) integrates factors identiﬁed by utility the-
ories,14,15 Common-Sense Model of Health
Behavior,16 Protection Motivation Theory14 and
Theory of Planned Behavior17 as motivating
health-related behaviours. We developed a new
model because none of these existing models
account for decisional conﬂict; instead, they
explain intentions and behaviour. Integrated
models can advance theory and research by com-
bining factors found to be potent predictors and
mechanisms within related behavioural domains
to enhance explanatory power in predicting
behaviour in a new domain.18,19 We integrated
those factors that are likely to inﬂuence prenatal
testing decision making; to date, their contribu-
tions to decisional conﬂict have not yet been
empirically evaluated. These factors include per-
ceived beneﬁts from normal results (Utility Theo-
ries14,15,20), test response eﬃcacy (Protection
Motivation Theory14,21,22), condition coherence
(Common-Sense Model of Health Behavior16,23),
child-related worry (Common-Sense Model of
Health Behavior7,16,24–26), and motivation to
comply with doctors’ perceived preferences (The-
ory of Planned Behavior6,27). In addition, factors
suggested by empirical research but which have
not been clearly integrated into theory include
perceived disagreement with other parent’s pref-
erence,28 parity,20,29,30 and the characteristics of
the condition tested for.29,31–34
Prospective parents engaged in deliberative
decision making will consider the pros and
cons of receiving test results.15 The beneﬁts
from normal test results include reassurance
about the health of the foetus.20 Not perceiving
beneﬁts from normal test results should pro-
mote decisional conﬂict.
Test response eﬃcacy, deﬁned as perceptions
of the test’s ability to accurately detect abnor-
malities, can also inﬂuence decisions to undergo
testing.21,22 If couples believe prenatal diagnos-
tic testing can provide reliable information, then
they are likely to value the test and feel more
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conﬁdent about their decision.16 Lower test
response eﬃcacy, however, should lead to
greater decisional conﬂict.
In reaching a decision about prenatal diag-
nostic testing, couples typically attempt to gain
a better understanding of the genetic condition
(e.g., possible phenotypes, clinical outcomes
etc.) to form a coherent account of the condi-
tion. This condition coherence (i.e., the extent
to which a health threat ‘makes sense’) is a key
determinant of protective behaviours such as
genetic screening.23 When presented with a
health threat, individuals combine several cog-
nitive attributes (e.g., the cause of the threat,
potential treatment) to make sense of the
threat and to create their own ‘condition
coherence’, or understanding of the condition.
As such, individuals who appreciate the genetic
aetiology of the condition should feel relatively
conﬁdent that genetic diagnostic testing is the
appropriate tool to detect that condition,
whereas those with low condition coherence
should experience greater decisional conﬂict.
Child-related worry has also been shown to
predict prenatal testing intentions.7,24,25 Theory
and research demonstrate that worry signiﬁ-
cantly inﬂuences health decisions and does so
independently of risk-related cognitions.26 Deci-
sional conﬂict should be greater for prospective
parents worried about the health of the foetus
and thus likely to deliberate the pros and cons of
testing.
Interpersonal dynamics within the wider
social environment in which prenatal testing
decisions take place can also inﬂuence the deci-
sion-making process.17,35 Motivations to com-
ply with the perceived preferences of others
can critically inﬂuence decisional conﬂict, par-
ticularly given the extent to which being
accountable to others and maintaining harmo-
nious relationships with signiﬁcant others are
important determinants of satisfactory repro-
ductive decision making.36 Perceiving diﬀer-
ences of opinion from that of the other parent
may complicate prenatal testing decision mak-
ing and arouse decisional conﬂict.28 Therefore,
we expect that perceived disagreement will lead
to greater decisional conﬂict.
Health professionals are also inﬂuential in
prenatal diagnostic testing decision making.27
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Figure 1 Proposed integrated model of
psychosocial factors influencing prenatal
diagnostic testing decisional conflict.
Lines with crossbars indicate
relationships not supported by the study
findings.
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Perceptions of their views on prenatal testing
can contribute to decisional conﬂict. They are
ethically bound to operate in a non-directive
manner, but the simple fact that they oﬀer
diagnostic testing to prospective parents can be
viewed as a sign of endorsement.37 Couples
who feel compelled to comply with their doc-
tors’ perceived preferences may feel less certain
that their decision reﬂects their personal prefer-
ences. Hence, greater decisional conﬂict may
arise for couples high in motivation to comply
with doctors’ perceived preferences.
Evidence indicates that uncertainty surround-
ing reproductive decisions is also likely to be
inﬂuenced by ﬁrst-hand experiences with preg-
nancies,20,38,39 and the age of onset and curabil-
ity of the condition.29 Previous experience with
pregnancies can provide experiential knowledge
of the issues associated with prenatal testing.30,37
Compared with parents, childless couples are
less likely to have already faced issues about pre-
natal testing and could therefore experience
greater decisional conﬂict. With regard to the
role of conditions’ age of onset, Canadian and
American surveys showed that genetic testing is
more acceptable when used to diagnose early-
onset illnesses than adult-onset diseases.31,32
Consequently, decisional conﬂict should be
greater when the conditions tested for are late-
onset. Finally, the severity of a condition can
also inﬂuence decisions around prenatal test-
ing.29 One study revealed that participants were
more accepting of reproductive technologies
when used to test for conditions perceived to
reduce lifespan and quality of life.33 Managing
certain diseases (e.g. sickle cell disease, an incur-
able birth onset condition) may require lifelong
medical care and surveillance, as well as reliance
on experts and specialized medical centres. The
clinical severity of the condition, as well as the
psychological and economic impacts of the dis-
ease, is likely to trigger internal ethical debates
that call upon personal judgements about the
quality of life the individual would have if born
with the condition.40,41 Such considerations,
weighed against the beneﬁts of being born at all,
would need time to be carefully deliberated.
However, decisions about prenatal testing are
time pressured as they need to be made within a
given time frame to allow termination of preg-
nancy if the parents decided to do so. According
to decision-making theory,9 decisions made
under time pressure lead to decisional conﬂict.
Hence, parents caught between their parental
duties and the perceived quality of life of their
future children are likely to experience great
uncertainty about prenatal testing. Decisional
conﬂict should be greater for curable conditions,
than for non-curable, fatal conditions.
Objective and hypotheses
We conducted an online study to test the pro-
posed model of psychosocial (perceived beneﬁts
from normal results; test response eﬃcacy; con-
dition coherence; child-related worry; perceived
disagreement with other parent’s preference;
motivation to comply with doctors’ perceived
preferences) and clinical characteristics (condi-
tion’s age of onset and curability) promoting
decisions conﬂict about prenatal diagnostic test-
ing. Aware that presenting information about
foetal abnormalities and birth defects could
trigger stress amongst expectant parents, we
recruited adults from the general population to
respond to hypothetical scenarios describing pre-
natal diagnostic testing for genetic conditions.
We predicted that lower perceived beneﬁts from
normal results, lower test response eﬃcacy, lower
condition coherence, greater child-related worry,
perceived disagreement with the other parent,
and greater motivation to comply with doctors’
perceived preferences would independently pre-
dict greater decisional conﬂict. Furthermore, we
hypothesized that being childless and considering
testing for a curable or an adult-onset condition
would each predict greater decisional conﬂict.
Method
Recruitment and participants
The university’s ethics committee approved this
study. Participants were recruited through
announcements to community and web-based
organizations throughout New Zealand. Eligibil-
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ity criteria included ﬂuency in English, age of
18 years or over, and current involvement in a
romantic relationship. Altogether, 345 women and
112 men (Mage = 32.68 years; SD = 8.61 years)
completed the study. Approximately two-thirds
(n = 291) had one child or more. The majority
either had no religious aﬃliation (Agnostic: n = 22;
Atheist: n = 33; no religion: n = 176) or aﬃliated
with Christianity (n = 188). Participants who
self-identiﬁed with more than one ethnicity were
categorized using a standard procedure for priori-
tizing ethnicity.42 Most participants were New
Zealand European (n = 328), other European
(n = 54), or Maori (n = 25); 10.4% identiﬁed with
other ethnicities.
Design and procedures
The study utilized a 2 (Onset: Birth vs. Adult-
hood) 9 2(Curability: No Cure vs. Available Cure)
between-subjects design. After entering the study
website and providing consent, participants were
randomly assigned to read one of four hypothetical
scenarios, which varied only in terms of the age of
onset (‘symptoms appear slowly between the ages of
30 and 50 years’ vs ‘symptoms are present from
birth’) and curability of the condition (‘no cure’ vs ‘a
cure’) (Appendix A). The adulthood ages of onset
reﬂected those of existing diseases, such as early-
onset Alzheimer’s disease.43–45 Participants then
completedmeasures of decisional conﬂict, perceived
beneﬁts from receiving normal results, test response
eﬃcacy, condition coherence, child-related worry,
perceived disagreement with other parent’s prefer-
ence motivation to comply with doctors’ perceived
preferences, and demographic information (includ-
ing parenthood status). The questionnaire ended
with debrieﬁng information about prenatal testing
and sources to consult for thosewantingmore infor-
mation about genetic conditions.
Measures
Unless otherwise stated, all items were rated
from 3 (strongly disagree) to +3 (strongly
agree). Items were averaged to generate scores
after reverse-scoring negatively worded items
(rev).
Decisional conﬂict
We adapted the most conceptually relevant
subscale of the Decisional Conﬂict scale,46 that
is, the decisional uncertainty subscale. The six
items, scored from 0 (strongly disagree) to 6
(strongly agree), were as follows: ‘The decision
to undergo or not prenatal testing would be
hard for me to make’; ‘I feel I know the risks
and beneﬁts of the procedure involved (rev)’; ‘I
am unsure about what I would do in this situa-
tion’; ‘I would need more advice and informa-
tion about my options before making a
decision about prenatal testing’; ‘It is clear to
me what choice would be the best for me
(rev)’; and ‘It would be hard to decide which
are the most important to me: the risks or the
beneﬁts associated with the test’. Internal con-
sistency was high; Cronbach’s a = 0.86.
Perceived beneﬁts from receiving normal results
Four items was used to assess anticipated bene-
ﬁts from receiving normal test results: ‘Knowing
that my unborn child did not have the genetic
mutation. . . 1). . . would help me feel less anx-
ious about the pregnancy, 2). . . would make me
feel reassured about the health of my unborn
child, 3). . . would increase my conﬁdence
regarding the progress/outcomes of the preg-
nancy’, and 4) ‘The test results would resolve the
uncertainty about whether or not my unborn
child has this condition’; a = 0.85.
Test response eﬃcacy
A three-item measure was used to assess beliefs
that prenatal genetic testing can reliably detect
foetal genetic abnormalities: ‘Undergoing this
prenatal test would clearly indicate the pres-
ence of this condition’; ‘I do not feel conﬁdent
that this prenatal test would give accurate
information about whether or not my unborn
child would have the condition (rev)’; and ‘This
prenatal test could indicate whether or not
something is wrong’; a = 0.71.
Condition coherence
An adapted subscale from the Illness Percep-
tions Questionnaire-Revised47 included the
ª 2015 John Wiley & Sons Ltd
Health Expectations, 19, pp.388–402
Decisional uncertainty and prenatal testing, C Muller and L D Cameron392
items: ‘The symptoms of this condition are
puzzling to me (rev)’; ‘I have a clear picture/
understanding of this condition’; ‘This condi-
tion is a mystery to me (rev)’; ‘I don’t fully
understand this condition (rev)’; and ‘This con-
dition makes sense to me’; a = 0.89.
Child-related worry
The child-related worry measure48 included
three items: ‘If I/we were expecting a child,
I would worry about it being aﬀected with
this genetic condition’; ‘I am concerned my
child may be born with this genetic condi-
tion’; and ‘The thought of giving birth to a
child with his genetic condition bothers me’;
a = 0.87.
Perceived disagreement
Anticipated diﬀerences of opinions from part-
ners were assessed using scores of testing
interest and normative beliefs–partner. Testing
interest (i.e., interest in undergoing prenatal
testing) was assessed by a six-item measure:
‘Undergoing this prenatal test would be too
distressing for me (rev)’; ‘For me, even a slight
increase in the chance of miscarriage would be
unacceptable (rev)’; ‘This prenatal test would
expose my unborn child to unnecessary risk
(rev)’; ‘Prenatal testing would be of no beneﬁt
to myself or my family (rev)’; ‘It would be
important to get the test’; and ‘I would request
the test’; a = 0.91. Normative beliefs–partner
was assessed with ‘How much would your
partner/spouse want you to undergo prenatal
testing?’ (0: not at all; 6: very much). First, the
z scores for both scales were computed. Testing
interest z scores ranged from 1.88 to 1.99,
and normative beliefs – partner z scores ranged
from 1.47 to 1.26. Next, a constant of 2 was
added to both z scores so that all values would
be positive. Z scores now ranged from 0.12 to
3.99 for testing interest and from 0.53 to 3.26
for normative beliefs – partner. Scores were
plotted (Fig. 2), and participants were catego-
rized into four groups based on where their
scores fell within these four quadrants; a method
frequently used by health researchers.49–51 The
ﬁrst quadrant ‘self against/other for testing’
comprised participants who were against prena-
tal testing but who perceived their partner/
spouse would be in favour (n = 100, 21.9%).
The second quadrant ‘perceived agreement for
testing’ comprised 185 individuals (40.5%). The
third quadrant ‘perceived agreement against
testing’ included 151 individuals (33%). The
ﬁnal quadrant ‘self for/other against testing’
included participants who were in favour of
prenatal testing but who perceived their partner/
spouse would be against it (n = 21, 4.6%).
Motivation to comply with doctors’ perceived
preferences
Willingness to follow doctors’ perceived prefer-
ences for prenatal testing was measured with
the item: ‘I would undergo prenatal testing if
it was important to my doctor/obstetrician/
midwife’.
Demographic information
Participants reported their gender, age, rela-
tionship status, number of children, religious
aﬃliation, and ethnicity.
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Analytical strategy
Data were analysed using SPSS v20. Diﬀerences
in socio-demographic characteristics between
the four Onset and Curability conditions and
the four Diﬀerences of Opinions groups were
assessed with Pearson v2 (for categorical vari-
ables) and ANOVA (for continuous variables).
Correlation coeﬃcients were computed to assess
the bivariate relationships between decisional
conﬂict and the other variables. The main and
interaction eﬀects of curability, age of onset, and
number of children (none vs. at least one) on
decisional conﬂict were tested using regression
analyses. A set of three dummy variables were
created to compare the four Diﬀerences of Opin-
ion groups, with each dummy variable compar-
ing ‘the self against/other for testing’ group with
one of the other three groups. The relationships
between decisional conﬂict and its hypothesized
predictors were tested through regression analy-
ses. Signiﬁcance level was set at P < 0.05.
Results
Demographic differences for the four condition
groups and the four differences of opinions groups
The four Onset and Curability conditions were
equivalent in terms of gender, age, number of
children, religious aﬃliation, and ethnicity (all
P’s > 0.05). Similarly, the four Diﬀerences of
Opinions groups did not diﬀer in terms of assign-
ment to Onset conditions, assignment to Curabil-
ity conditions, gender, age, number of children,
religious aﬃliation, and ethnicity (all P’s > 0.05).
Descriptive statistics and correlational
relationships for decisional conflict and the
demographic, clinical, and psychosocial variables
Overall, participants reported moderate deci-
sional conﬂict and varied in their interest in
testing (Table 1). They slightly agreed that
receiving normal test results was beneﬁcial and
moderately agreed that prenatal testing could
reliably detect genetic conditions. Participants
varied in condition coherence. They generally
had a slight tendency to worry about the
health of the unborn child and would be
somewhat motivated to undergo prenatal test-
ing if this was important to their doctors.
Decisional conﬂict did not correlate with
curability or onset. As predicted, decisional
conﬂict signiﬁcantly correlated with all of the
psychosocial variables. Greater decisional con-
ﬂict was associated with perceiving normal
results as beneﬁcial, doubting the test’s reliabil-
ity, lacking a coherent understanding of the
condition, worrying about the health of the
unborn child, being motivated to comply with
doctors’ perceived preference regarding testing,
being interested in undergoing prenatal testing,
and being childless (Table 1). In addition, deci-
sional conﬂict did not correlate with most
demographic variables, including gender.
Psychosocial and clinical variables as
independent predictors of decisional conflict
Regression analyses were conducted to test the
main and interaction eﬀects of curability (fatal
vs. not fatal) and age of onset (early vs. late)
on decisional conﬂict. Contrary to predictions,
curability and age of onset did not inﬂuence
decisional conﬂict (P’s > 0.05). Hence, they
were excluded from the ﬁnal analyses.
Contrary to hypotheses, greater (not lower)
perceived beneﬁts from negative results pre-
dicted greater decisional conﬂict (Table 2). As
hypothesized, lower test response eﬃcacy, lower
condition coherence, greater child-related worry,
perceived diﬀerences in opinions between par-
ents, greater motivation to comply with doctors’
perceived preferences, and being childless inde-
pendently predicted greater decisional conﬂict.
We conducted exploratory analyses (at
P < 0.01) to test whether Diﬀerences of Opin-
ions interacted with the study variables in pre-
dicting decisional conﬂict, No clear patterns of
trends emerged, suggesting that the observed
patterns of relationships of other factors with
decisional conﬂict are unaﬀected by perceived
diﬀerences of opinions in the couple.
Finally, analyses conducted on the parents
yielded the same patterns of associations
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between the predictor variables and decisional
conﬂict.
Discussion and conclusions
For couples, having to choose between accept-
ing and declining prenatal diagnostic testing is
likely to trigger decisional conﬂict because each
option is emotionally charged and involves
weighing risks against beneﬁts.52 Health profes-
sionals can best help prospective parents make
this decision if they understand what factors
may create decisional conﬂict. Given the pau-
city of theory and research on predictors of
decisional conﬂict in the context of prenatal
testing, we proposed and tested a model of
psychosocial and clinical factors contributing
to prenatal diagnostic testing decisional conﬂict
(Fig. 1). The ﬁndings largely supported this
model.
Motivation to comply with doctors’ per-
ceived preferences and perceived disagreement
with partner emerged as the strongest predic-
tors of decisional conﬂict. Participants who
were motivated to follow doctors’ preferences
and/or who perceived disagreement with their
partner/spouse were the most conﬂicted about
testing. These ﬁndings extend previous evidence
on the roles of social inﬂuences in reproductive
choices53 by demonstrating the strong links of
these two social inﬂuence factors on decisional
conﬂict. During pregnancy, women tend to
seek diﬀerent providers for diﬀerent types of
support.54,55 For informational support (e.g.,
provision of facts), expectant parents usually
consult medical professionals.55 Our ﬁndings
suggest that motivations to comply with per-
ceived recommendations of health professionals
are associated with greater uncertainty about
prenatal testing. It is also possible that the cau-
sal relationship is reversed, and that greater
uncertainty about prenatal testing enhances
motivations to follow perceived health profes-
sionals’ preferences. Either way, our ﬁndings
suggest that parents who express preferences to
act in accordance with medical experts may
feel particularly confused by the complex
issues surrounding prenatal testing and mayTa
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beneﬁt from genetic counselling. This is of note-
worthy importance as non-directiveness is cen-
tral to genetic counselling, which means that
professionals cannot deliberately withhold informa-
tion or inﬂuence patients’ decisions.56–58
For emotional support (e.g., empathetic
listening and reassurance), expectant parents typ-
ically turn to their partners59 with the expecta-
tions that, together, they will deliberate the issues
at stake, reach an agreement, and provide each
other with reassurance over their choice.20 Fam-
ily planning decisions reﬂect people’s values as
independent individuals, but also as united cou-
ples.60 The need for partnership between men
and women in these moments has been widely
recognized.61–63 These ﬁndings provide evidence
that perceived incongruence of opinions can
aggravate decisional conﬂict. This perceived lack
of unity may complicate the deliberative process,
potentially inducing emotional distress and lead-
ing them to hesitate about prenatal testing. From
a counselling perspective, probes into the individ-
ual preferences of both prospective parents could
reveal discrepancies of opinions that can be tar-
geted and potentially resolved through guided
discussions.
These ﬁndings on the roles of expectations
of partners and providers in generating deci-
sional conﬂict are particularly important in
the light of sociological and anthropological
research suggesting that social expectations
about prenatal testing are growing stronger.
With the wide availability of prenatal testing in
Western countries, it is likely to be perceived
as self-evident.64,65 Increasingly, individuals are
likely to feel social pressures to be a ‘good par-
ent’ and to not only take the test in the ‘best
interests’ of the unborn child,66 but also to
accept that child unconditionally, except in the
case of a severe disability resulting in a life of
suﬀering where termination would arguably be
less morally objectionable.67 For some parents,
however, the concepts of ‘best interests’ and
‘unconditional acceptance’ may not always be
compatible. On the one hand, these parents
may view prenatal testing as being in the inter-
est of the child and therefore lean towards tak-
ing the test. Simultaneously, they may hesitate
to take the test by fear of receiving abnormal
results, a situation that would make them con-
sider termination because of their doubts
towards their own abilities to raise a child spe-
cial needs.25,68 These individuals, caught in a
perceived ‘reproductive accountability’,70 may
fear being misunderstood by signiﬁcant others,
such as the other parent of their unborn child
or their health provider. Hence, parents-to-be
could feel torn between their desire to fulﬁl
their parental duties and the need to resolve
the moral and psychological implications
related to abnormal test results; these anxieties
are likely to be greater for ﬁrst-time parents
who lack experiential knowledge.70
Other factors independently predicting deci-
sional conﬂict included response eﬃcacy and
condition coherence. Response eﬃcacy has
been demonstrated to inﬂuence decisions about
protective behaviours, and these ﬁndings show
Table 2 Regression analyses on decisional conflict in prenatal testing
B SE B b R2 F
Self against, other for vs. perceived agreement for 0.48 0.12 0.24*** 0.25 16.24***
Motivation to comply with doctors’ perceived preference 0.17 0.04 0.22***
Self against, other for vs. perceived agreement against 0.37 0.13 0.18**
Self against, other for vs. self for, other against 0.55 0.22 0.18**
Test response efficacy 0.21 0.06 0.17***
Child-related worry 0.18 0.05 0.17***
Number of children (0 vs. 1+) 0.38 0.13 0.12**
Condition coherence 0.21 0.07 0.13**
Benefits from normal results 0.18 0.09 0.11*
***P < 0.001; **P < 0.01; *P < 0.05.
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that its role extends to the domains of deci-
sional conﬂict and prenatal testing. If prenatal
tests are perceived to be unreliable, then people
are likely to experience doubts that exacerbate
decisional conﬂict. Related to response eﬃcacy
is condition coherence (i.e. or understanding
the link between the genetic origin of a health
threat and the genetic mutation being tested
for). Condition coherence can increase motiva-
tions to obtain the genetic test.71,72 Our ﬁnd-
ings suggest the importance of educating
expectant couples about the genetic conditions
tested for and the tests’ detection rates, so as
to increase informed decisions and decrease
uncertainty.
Perceiving normal results as beneﬁcial and
worrying about the health of the foetus pre-
dicted higher decisional conﬂict. Feelings of
worry are often key motivators of screening and
protection behaviours.48,73 This relationship was
reﬂected in our study by the positive correlations
linking worry about the health of the unborn
child, interest in undergoing prenatal testing,
and perceived beneﬁts from receiving normal
results. Parents-to-be may be divided between
their desires to be provided with (anxiety-
reducing) normal results and their fears to
receive (anxiety-provoking) abnormal test
results. It may be that understanding the value
of normal results and therefore perceiving the
possible presence of foetal abnormalities
enhances the salience of risks about these abnor-
malities which, in turn, increases decisional con-
ﬂict. Hence, parents concerned about the health
of the foetus may report interest but also hesita-
tion in prenatal testing if they fear that test result
could bring about an undesired outcome. Fur-
ther studies could assess the respective roles of
perceived beneﬁts from normal results and antic-
ipated harms from abnormal results in deci-
sional conﬂict.
Decisional conﬂict did not vary by the age
of onset or curability of the genetic condition,
suggesting that prenatal testing decisions may
be equally diﬃcult regardless of these condition
characteristics. Decisional conﬂict did not vary
by the age of onset or curability of the genetic
condition, suggesting that decisions about pre-
natal testing for this type of neurological con-
dition may be equally diﬃcult regardless of
these condition characteristics. The neurologi-
cal condition described could be suﬃciently
threatening even when its onset is in adulthood
and its potential severity is low (i.e., it is
described as curable) that the range in per-
ceived severity of the four conditions was too
minimal to lead to diﬀerences in the extent to
which it inﬂuences decisional conﬂict. Never-
theless, age of onset and curability could inﬂu-
ence decisional conﬂict for tests of other
conditions, particularly those for which poten-
tial parents have considerable familiarity and
which involve familiar treatments (e.g., blind-
ness, hereditary cancer, or cystic ﬁbrosis).
Whilst decisional conﬂict did not vary by gen-
der, it did so as a function of parity: Childless
participants reported greater hesitation relative
to participants with children. Diﬀerences in expe-
riential knowledge (i.e. everyday experiences)
may account for these ﬁndings. Abel and
Browner74 diﬀerentiated empathic knowledge
(acquired through interactions with others) from
embodied knowledge (derived from personal
physical experience as such pregnancy). Both
types of subjective knowledge can shape health
behaviours. Indeed, individuals can draw
from these past experiences and make relatively
informed health-related decisions in the fu-
ture.75,76 Contrary to childless participants, par-
ents can draw from both types of experiential
knowledge: women from having ‘embodied’
pregnancy, and partners from having been clo-
sely associated to it. Such familiarity with preg-
nancy and related issues would facilitate future
reproductive choices. It might also reduce the
‘burden of anticipation’ (Wexler, 1979, cited in
Ref. 77, p. 63) experienced by individuals facing a
new situation, such as childless individuals facing
decisions about prenatal testing. In the study,
although some childless couples may have experi-
enced non-viable pregnancies, the majority are
unlikely to have had ﬁrst-hand experience with
prenatal care or to have previously engaged in
debates about reproductive issues, and they may
be more conﬂicted about making a decision
about prenatal testing as a consequence.60
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Several study limitations warrant comment.
First, we used hypothetical scenarios to elicit
views on prenatal testing in the general popu-
lation, for conditions described but not
named; an approach that may be criticized for
potentially producing ﬁndings not easily gener-
alizable to ‘real life’ situations. However, this
well-accepted means of investigation23,77–80
allowed us to systematically manipulate infor-
mation hypothesized to inﬂuence decision con-
ﬂict (i.e., age of onset or curability) and to
test our model with a sample who is likely to
face these types of prenatal testing decisions in
the future under conditions safe from creating
signiﬁcant distress. Nonetheless, caution is wa-
rranted when extending the present ﬁndings to
actual would-be parents and a critical next step
in this research area is to conduct a study testing
the model with expecting parents who are facing
prenatal testing decisions. Second, our choice of
hypothetical scenarios prevented us from con-
ducting follow-up analyses on decisional satis-
faction and regret. A critical step for future
research would be to assess decisional satisfac-
tion and regret in individuals experiencing deci-
sional conﬂict during pregnancy. These studies
would yield valuable information on how to
maximize decision satisfaction in individuals ini-
tially unsure about their choice. Finally, the cor-
relational nature of the ﬁndings precludes
inferences of causality. The integrative model
can be used to guide experimental studies in
which these factors are manipulated (e.g.,
through health communications) to determine
their inﬂuence on decisional conﬂict.
The present ﬁndings have potential clinical
and educational implications. For some indi-
viduals, choosing between accepting and
declining prenatal testing could create conﬂict.
Health professionals providing pregnancy care
can facilitate decision making and reduce
distress by addressing the key psychosocial
aspects of prenatal testing identiﬁed by the
integrated model. Clinicians may be able to
reassure hesitant parents-to-be by ‘normalizing’
their state of anxiety as feeling conﬂicted about
prenatal testing is common amongst expectant
parents, especially amongst ﬁrst-time parents.
In keeping with the patient-centred approach,
professionals could reassure their patients and
emphasize that many other couples in a similar
situation also feel anxious. This emphasis might
help patients fell less isolated and more inclined
to discuss concerns they might have otherwise
kept to themselves by fear of being judged for
having unique unreasonable fears.81,82 Anxious
patients might also beneﬁt from tasks aimed at
reducing uncertainty, such as values clariﬁcation
exercises present in some decision aids.83,84
Health professionals may be able to minimize
couples’ conﬂict by clarifying issues important to
them, such as the prospects of receiving test
results, the reliability of the test, and worries
about the health of the unborn child. More time
may be needed to explore these issues with new
parents than with couples who already have
children. The deliberative process about whe-
ther or not to take the test is likely to continue
at home,20 especially if future parents disagree.
These conﬂicting couples might ﬁnd decision
aids (i.e. informational resources, supposed to
be an adjunct to counselling) particularly help-
ful in reaching a common decision.13,85,86
Conclusion
By drawing on several decision-making theories
to identify factors with established associations
with health behaviour decisions,16,17,21,22,46,80,87
we developed an integrated model delineating
their independent roles in exacerbating or mini-
mizing conﬂict over behavioural decisions in the
context of prenatal genetic testing. This multithe-
ory approach18 provided a rich understanding of
the issues at stake in prenatal testing decision
making. Our ﬁndings suggest that couples faced
with prenatal testing may experience decisional
conﬂict, but that psychological distress could be
reduced if the key psychosocial concerns are
addressed.
Sources of funding
None received.
ª 2015 John Wiley & Sons Ltd
Health Expectations, 19, pp.388–402
Decisional uncertainty and prenatal testing, C Muller and L D Cameron398
Conflict of interest
None declared.
References
1 Amor DJ. Future of whole genome sequencing.
Journal of Paediatrics and Child Health, 2014; 51:
251–254.
2 Chiu RWK. Noninvasive prenatal testing by
maternal plasma DNA analysis: current practice and
future applications. Scandinavian Journal of Clinical
& Laboratory Investigation, 2014; 74: 48–53.
3 Statistics New Zealand. Births and deaths, 2010.
Available at: http://www.stats.govt.nz/browse_
for_stats/population/births/BirthsAndDeaths_
HOTPYeDec10.aspx. Accessed 10.02.2012.
4 Martin JA,Hamilton BE, Ventura SJ, OstermanMJK,
Wilson EC,Mathews TJ.Births: Final Data for 2010.
Centre forDisease Control and Prevention, 2012.
Document available at: http://www.cdc.gov/nchs/data/
nvsr/nvsr61/nvsr61_01.pdf. Accessed 10.02.2012.
5 Morris JK, Wald NJ, Mutton DE, Alberman E.
Comparison of models of maternal age-speciﬁc risk
for Down syndrome live births. Prenatal Diagnosis,
2003; 23: 252–258.
6 Hook EB. Rates of chromosome abnormalities at
diﬀerent maternal ages. Obstetrics & Gynecology,
1981; 58: 282–285.
7 The American College of Obstetricians and
Gynecologists. ACOG Practice Bulletin No. 88:
invasive prenatal testing for aneuploidy. Obstetrics
& Gynecology, 2007; 110: 1459–1467.
8 Bell M, Stoneman Z. Reactions to prenatal testing:
reﬂection of religiosity and attitudes toward
abortion and people with disabilities. American
Journal of Mental Retardation, 2000; 105: 1–13.
9 Janis IL, Mann L. Decision Making. New York:
The Free Press, 1977.
10 van den Berg M, Timmermans DRM, Kate LP,
van Vugt JMG, van der Wal G. Are pregnant
women making informed choices about prenatal
screening? Genetics in Medicine, 2005; 7: 332–338.
11 Kaiser AS, Ferris LE, Pastuszakm AL et al. The
eﬀects of prenatal group genetic counselling on
knowledge, anxiety and decisional conﬂict: issues for
nuchal translucency screening. Journal of Obstetrics
& Gynaecology, 2002; 22: 246–255.
12 Bekker HL, Hewison J, Thornton JG. Applying
decision analysis to facilitate informed decision
making about prenatal diagnosis for Down
syndrome: a randomised controlled trial. Prenatal
Diagnosis, 2004; 24: 265–275.
13 Nagle C, Gunn J, Bell R et al. Use of a decision
aid for prenatal testing of fetal abnormalities to
improve women’s informed decision making:
a cluster randomised controlled trial. British
Journal of Obstetrics and Gynaecology, 2008; 115:
339–347.
14 Boer R, Seydel ER. Protection motivation theory.
In: Conner M, Norman P (eds) Predicting Health
Behaviour: Research and Practice With Social
Cognition Models. Buckingham: Open University
Press, 1995: 95–120.
15 vonNeumann J, Morgenstern O. Theory of Games
and Economic Behavior (2d rev. ed.), xviii.
Princeton, NJ: Princeton University Press,
1947: 641 p.
16 Leventhal H, Brissette I, Leventhal EA. The
common-sense model of self-regulation of health
and illness. In: Cameron LD, Leventhal H (eds) The
Self-Regulation of Health and Illness Behaviour.
London: Routledge, 2003: 42–65.
17 Ajzen I. The Theory of Planned Behavior.
Organizational Behavior and Human Decision
Processes, 1991; 50: 179–211.
18 Broadstock M, Michie S. Processes of patient
decision making: theoretical and methodological
issues. Psychology and Health, 2000; 15: 191–204.
19 Michie S, Webb TL, Sniehotta FF. The importance
of making explicit links between theoretical
constructs and behaviour change techniques.
Addiction,2010; 105: 1897–1898.
20 Humphreys L, Cappelli M, Hunter A, Allanson J,
Zimak A. What is the signiﬁcance of attendance by
the partner at genetic counselling for advanced
maternal age? Psychology, Health & Medicine, 2003;
8: 266–278.
21 Rogers RW. A protection motivation theory of fear
appeals and attitude change. The Journal of
Psychology, 1975; 91: 93–114.
22 Rogers RW. Cognitive and physiological processes
in fear appeals and attitude change: a revised
theory of protection motivation. In: Cacioppo JT,
Petty RE (eds) Social Psychophysiology: A
Sourcebook. New York: The Guildford Press,
1983: 153–176.
23 Cameron LD, Marteau TM, Brown PM, Klein W,
Sherman K. Communication strategies for
enhancing understanding of the behavioral
implications of genetic and biomarker tests for
disease risk: the role of coherence. Journal of
Behavioral Medicine, 2012; 5: 286–298.
24 van den Berg M, Timmermans DRM, Knol DL
et al. Understanding pregnant women’s decision
making concerning prenatal screening. Health
Psychology, 2008; 27: 430–437.
25 Muller C, Cameron LD. Trait anxiety, information
modality, and responses to communications about
prenatal genetic testing. Journal of Behavioral
Medicine, 2014; 37: 988–999.
ª 2015 John Wiley & Sons Ltd
Health Expectations, 19, pp.388–402
Decisional uncertainty and prenatal testing, C Muller and L D Cameron 399
26 Cameron LD, Chan CKY. Designing health
communications: harnessing the power of aﬀect,
imagery, and self-regulation. Social and Personality
Psychology Compass, 2008; 2: 262–282.
27 Ahmed S, Bryant LD, Tizro Z, Shickle D. Is advice
incompatible with autonomous informed choice?
Women’s perceptions of advice in the context of
antenatal screening: a qualitative study. Health
Expectations, 2014; 17: 555–564.
28 W€atterbj€ork I, Blomberg K, Nilsson K,
Sahlberg-Blom E. Decision-making process of
prenatal screening described by pregnant women
and their partners. Health Expectations, 2013.
DOI: 10.1111/hex.12147.
29 Asplin N, Wessel H, Marions L, €Ohman SG.
Pregnant women’s perspectives on decision-making
when a fetal malformation is detected by ultrasound
examination. Sexual & Reproductive Healthcare,
2013; 4: 79–84.
30 Anderson G. Patient decision-making for clinical
genetics. Nursing Inquiry, 2007; 14: 13–22.
31 Genetics and Public Policy Center. Reproductive
genetic testing: What America thinks, 2004.
Available at: http://www.dnapolicy.org/images/
reportpdfs/ReproGenTestAmericaThinks.pdf.
Accessed 10.02.2012.
32 Martin S. Most Canadians welcome genetic testing.
Canadian Medical Association Journal, 2000; 163:
200.
33 Muller C, Shepherd D. Attitudes towards
reproductive technologies for humans. New Zealand
Journal of Social Sciences Online, 2009; 4: 225–238.
34 Boardman FK. The expressivist objection to
prenatal testing: the experiences of families living
with genetic disease. Social Science and Medicine,
2014; 107: 18–25.
35 Vennum A, Fincham FD. Assessing decision
making in young adult romantic relationships.
Psychological Assessment, 2011; 23: 739–751.
36 Browner CH, Preloran HM, Cox SJ. Ethnicity,
bioethics, and prenatal diagnosis: the amniocentesis
decisions of Mexican-origin women and their
partners. American Journal of Public Health, 1999;
89: 1658–1666.
37 Potter BK, O’Reilly N, Etchegary H et al.
Exploring informed choice in the context of
prenatal testing: ﬁndings from a qualitative study.
Health Expectations, 2008; 11: 355–365.
38 Bryant LD, Hewison J, Green J. Attitudes towards
prenatal diagnosis and termination in women who
have a sibling with Down’s syndrome. Journal of
Reproductive and Infant Psychology, 2005; 23:
181–198.
39 France EF, Locock L, Hunt K, Ziebland S, Field K,
Wyke S. Imagined futures: how experiential
knowledge of disability aﬀects parents’ decision
making about fetal abnormality.Health Expectations,
2012; 15: 139–156.
40 Wonkam A, de Vries J, Royal CD, Ramesar R,
Angwafo FF 3rd. Would you terminate a pregnancy
aﬀected by sickle cell disease? Analysis of views of
patients in Cameroon. Journal of Medical Ethics,
2014; 40: 615–620.
41 Garcıa E, Timmermans DR, van Leeuwen E.
Parental duties and prenatal screening: does an oﬀer
of prenatal screening lead women to believe that
they are morally compelled to test? Midwifery, 2012;
28: e837–e843.
42 Frazer. Selected health professional workforce New
Zealand 2002. In: Service NZHI (ed.). 2003. Available
at: https://www.health.govt.nz/system/ﬁles/documents/
publications/healthprofs02.pdf. Accessed 10.02.2012.
43 Josefson D. Doctors successfully screen embryos for
gene mutation linked to early onset Alzheimer’s.
British Medical Jornal, 2002; 324: 564.
44 Larner AJ, Doran M. Reply to Dr Raux et al.:
molecular diagnosis of autosomal dominant early
onset Alzheimer’s disease: an update. Journal of
Medical Genetics, 2005; 42: 793–795.
45 Spriggs M. Genetically selected baby free
of inherited predisposition to early-onset
Alzheimer’s disease. Journal of Medical Ethics, 2002;
28: 290.
46 O’Connor AM. Validation of a decisional
conﬂict scale. Medical Decision Making, 1995; 15:
25–30.
47 Moss-Morris R, Weinman J, Petrie KJ, Horne R,
Cameron LD, Buick D. The revised illness
perception questionnaire (IPQ-R). Psychology &
Health, 2002; 17: 1–16.
48 Cameron LD, Reeve J. Risk perceptions, worry, and
attitudes about genetic testing for breast cancer
susceptibility. Psychology & Health, 2006; 21: 211–230.
49 Morrison MA, Morrison T. The Psychology of
Modern Prejudice. Hauppauge, NY: Nova Science
Publishers, 2008; 332-viii.
50 McDonell MG, Kerbrat AH, Comtois KA, Russo J,
Lowe JM, Ries RK. Validation of the co-occurring
disorder quadrant model. Journal of Psychoactive
Drugs, 2012; 44: 266–273.
51 Shedler J, Mayman M, Manis M. The illusion of
mental health. American Psychologist, 1993; 48:
1117–1131.
52 van den BergM, Timmermans DR, ten Kate LP,
van Vugt JM, van derWal G. Informed decision
making in the context of prenatal screening. Patient
Education and Counseling, 2006; 63: 110–117.
53 Rowe H, Fisher J, Quinlivan J. Women who are
well informed about prenatal genetic screening delay
emotional attachment to their fetus. Journal of
Psychosomatic Obstetrics & Gynecology, 2009; 30:
34–41.
ª 2015 John Wiley & Sons Ltd
Health Expectations, 19, pp.388–402
Decisional uncertainty and prenatal testing, C Muller and L D Cameron400
54 Kukulu K, Buldukoglu K, Keser I et al.
Psychological eﬀects of amniocentesis on women
and their spouses: importance of the testing period
and genetic counseling. Journal of Psychosomatic
Obstetrics & Gynecology, 2006; 27: 9–15.
55 Rini C, Dunkel Schetter C, Hobel CJ, Glynn LM,
Sandman CA. Eﬀective social support: Antecedents
and consequences of partner support during
pregnancy. Personal Relationships, 2006; 13: 207–29.
56 McGillivray G, Rosenfeld JA,McKinlay Gardner RJ,
Gillam LH.Genetic counselling and ethical issues
with chromosomemicroarray analysis in prenatal
testing. Prenatal Diagnosis, 2012; 32: 389–395.
57 Pergament E, Pergament D. Reproductive decisions
after fetal genetic counselling. Best Practice &
Research. Clinical Obstetrics & Gynaecology, 2012;
26: 517–529.
58 Wessels T, Koole T, Penn C. ‘And then you can
decide’ – antenatal foetal diagnosis decision making
in South Africa. Health Expectations, 2014.
DOI: 10.1111/hex.12322.
59 Rini C, Dunkel Schetter C. The eﬀectiveness of
social support transactions in intimate relationships.
In: Davila J, Sullivan K (eds) Support Processes in
Intimate Relationships. New York, NY: Oxford,
2010: 26–67.
60 Kuppermann M, Norton ME, Gates E et al.
Computerized prenatal genetic testing decision-
assisting tool: a randomized controlled trial.
Obstetrics and Gynecology, 2009; 113: 53–63.
61 Caleshu C, Shiloh S, Price C, Sapp J, Biesecker B.
Invasive prenatal testing decisions in pregnancy
after infertility. Prenatal Diagnosis, 2010; 30:
575–581.
62 Durand M-A, Stiel M, Boivin J, Elwyn G.
Information and decision support needs of parents
considering amniocentesis: interviews with pregnant
women and health professionals. Health
Expectations, 2010; 13: 125–138.
63 Garcıa E, Timmermans DRM, van Leeuwen E.
Rethinking autonomy in the context of prenatal
screening decision-making. Prenatal Diagnosis, 2008;
28: 115–120.
64 De Jong A, Dondorp WJ, de Die-Smulders CEM,
Frints SGM, de Wert GMWR. Non-invasive
prenatal testing: ethical issues explored. European
Journal of Human Genetics, 2010; 18: 272–277.
65 Suter SM. The Routinization of prenatal testing.
American Journal of Law and Medicine, 2002; 8:
233–270.
66 Green J, Hewison J, Bekker H, Bryant L, Cuckle H.
Psychosocial aspects of genetic screening of
pregnant women and newborns: a systematic review.
Health Technology Assessment, 2004; 8: 1–109.
67 Garcίa E, Timmermans DRM, van Leeuwen E.
Reconsidering prenatal screening: an empirical –
ethical approach to understand moral dilemmas as a
question of personal preferences. Journal of Medical
Ethics, 2009; 35: 410–414.
68 Knoppers BM, Bordet S, Isasi RM. Preimplantation
genetic diagnosis: an overview of socio-ethical and
legal considerations. Annual Review of Genomics and
Human Genetics, 2006; 7: 201–221.
69 Burgess MM, D’Agincourt-Canning L. Genetic
testing for hereditary disease: attending to relational
responsibility. Journal of Clinical Ethics, 2001; 12:
361–372.
70 Etchegary H, Potter B, Howley H et al. The
inﬂuence of experiential knowledge on prenatal
screening and testing decisions. Genetic Testing,
2008; 12: 115–124.
71 Henneman L, Timmermans DRM, van der Wal G.
Public experiences, knowledge and expectations
about medical genetics and the use of genetic
information. Community Genetics, 2004; 7: 33–43.
72 Human Genetics Commission. Public Attitudes to
Human Genetic Information. People’s Panel
Quantitative Study Conducted for the Human
Genetics Commission. London: Crown, 2001.
73 Weinstein ND. Eﬀects of personal experience on
self-protective behavior. Psychological Bullertin,
1989; 105: 31–50.
74 Abel EK, Browner CH. Selective compliance with
biomedical authority and the uses of experiential
knowledge. In Lock M, Kaufert PA (eds) Pragmatic
Women and Body Politics. Cambridge: Cambridge
University Press, 1998: 310–326.
75 Rees G, Fry A, Cull A. A family history of breast
cancer: women’s experiences from a theoretical
perspective. Social Science & Medicine, 2001; 52:
1433–1440.
76 d’Agincourt-Canning L. The eﬀect of experiential
knowledge on construction of risk perception in
hereditary breast/ovarian cancer. Journal of Genetic
Counseling, 2005; 14: 55–69.
77 Kruglanski AW, Webster DM, Klem A.
Motivated resistance and openness to persuasion
in the presence or absence of prior information.
Journal of Personality & Social Psychology, 1993;
65: 861–876.
78 Sanderson SC, Michie S. Genetic testing for heart
disease susceptibility: potential impact on
motivation to quit smoking. Clinical Genetics, 2007;
71: 501–510.
79 Wright AJ, Sutton SR, Hankins M, Whitwell SCL,
Macfarlane A, Marteau TM. Why does genetic
causal information alter perceived treatment
eﬀectiveness? An analogue study. British Journal of
Health Psychology, 2012; 17: 294–313.
80 Claassen L, Henneman L, De Vet R, Knol D,
Marteau T, Timmermans D. Fatalistic responses to
diﬀerent types of genetic risk information: exploring
ª 2015 John Wiley & Sons Ltd
Health Expectations, 19, pp.388–402
Decisional uncertainty and prenatal testing, C Muller and L D Cameron 401
the role of Self-Malleability. Psychology & Health,
2009; 25: 183–196.
81 Hickerton CL, Aitken M, Hodgson J, Delatycki MB.
“Did you ﬁnd that out in time?”: new life trajectories
of parents who choose to continue a pregnancy where
a genetic disorder is diagnosed or likely. American
Journal of Medical Genetics Part A, 2012; 158A:
373–383.
82 Scully JL, Porz R, Rehmann-Sutter C. ‘You don’t
make genetic test decisions from one day to the
next’–using time to preserve moral space. Bioethics,
2007; 21 : 208–217.
83 O’Connor AM, Bennett CL, Stacey D et al.
Decision aids for people facing health treatment or
screening decisions. Cochrane Database Systematic
Review, 2003; 2: CD001431.
84 Sapp JC, Hull SC, Duﬀer S et al.Ambivalence toward
undergoing invasive prenatal testing: an exploration
of its origins. Prenatal Diagnosis, 2010; 30: 77–82.
85 Arimori N. Randomized controlled trial of decision
aids for women considering prenatal testing: the
eﬀect of the Ottawa Personal Decision Guide on
decisional conﬂict. Japan Journal of Nursing Science,
2006; 3: 119–130.
86 Jackson C, Cheater FM, Reid I. A systematic
review of decision support needs of parents making
child health decisions. Health Expectations, 2008;
11: 232–251.
87 Marteau TM, Weinman J. Self-regulation and the
behavioural response to DNA risk information: a
theoretical analysis and framework for future
research. Social Science & Medicine, 2006; 62:
1360–1368.
Appendix A
Hypothetical scenarios read by
participants
The manipulated information is italicised below
for clarity purposes, but not in the texts read
by participants.
Vividly imagine you are expecting a baby
and are at the beginning (under 12 weeks)
of the pregnancy. You hear about a pre-
birth test that can detect with more accuracy
than an ultrasound can whether the fetus is
aﬀected with a condition.
Now imagine that this condition is a disease
caused by a genetic mutation. The condition
involves a progressive deterioration in:
• Knowledge and understanding (cognitive
deterioration)
• Movements, with occurrence of involun-
tary movements (neurological deteriora-
tion), and
• Personality (deterioration of emotional
systems)
The condition is a progressive ‘adult-onset’
condition: symptoms appear slowly between the
ages of 30 and 50 years. [‘birth-onset’ condition:
symptoms are present from birth].On average,
in the entire population, parents have 1 chance
in 200 (0.5%) of having a child with this condi-
tion. No cure is currently available. Individuals
with this condition will live approximately 10 to
15 years after the onset of illness [A cure is cur-
rently available. Individuals with this condition
who receive the treatment will live after the
onset of illness and with minimal eﬀects of the
condition.]
The test consists of obtaining a small sample
of placenta or amniotic ﬂuid (these surround
the fetus). Sometimes under local anaesthetic
and with ultrasound guidance, a syringe is
used to collect small samples of the required
tissues.
This procedure may be mildly uncomfort-
able for the mother, as some angling to get
good views of the baby may be required.
There may also be discomfort due to
bruising and some cramps may be experi-
enced. However, these usually resolve
within 24 h.
The risk of procedure-related miscarriage is
between 0.5 and 1%. This means that
between 1 in 200 and 2 in 200 women will
miscarry following the procedure. There is
also a risk of natural miscarriage of 2% that
is present in all pregnancies at 10 weeks ges-
tation, whether or not the test is performed.
This procedure is done as an outpatient pro-
cedure and partners (or a support person/
Whanau/family support) can attend. The
test is performed between 10 and 15 weeks
of pregnancy (depending of the sample
required). Results are available 10–14 days
following the procedure. In New Zealand
and Australia, the test is usually free of
charge.
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